Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRBS.L Regulatory News (RBS)

  • There is currently no data for RBS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on RBS's remaining State Aid obligation

26 Jul 2017 16:31

RNS Number : 1995M
Royal Bank of Scotland Group PLC
26 July 2017
 

 

The Royal Bank of Scotland Group plc

 

Update on RBS's remaining State Aid obligation regarding the business previously described as Williams & Glyn

 

26 July 2017

 

 

Following the consultation process carried out by the European Commission ("EC") and a market testing exercise carried out by HM Treasury ("HMT"), RBS has been informed by HMT that an alternative remedies package has now been agreed in principle between HMT and the EC Commissioner responsible for competition.

 

 

This revised package is focused on the following two remedies to promote competition in the market for banking services to small and medium enterprises ("SMEs") in the UK.

 

· A £425m Capability and Innovation Fund, to be administered by an independent body, that will grant funding to a range of competitors in the UK banking and financial technology sectors; and

· An Incentivised Switching Scheme which will provide £275m of funding for eligible challenger banks to help them incentivise SME customers of the business previously described as Williams & Glyn to switch their accounts and loans from RBS paid in the form of "dowries" to the receiving bank. An additional £75m will be made available by RBS to cover customers' costs of switching.

 

This revised package will be submitted to the EC's College of Commissioners for approval and if agreed will form the basis of a new term sheet in relation to RBS's remaining State Aid commitments. It is expected to come into effect during H2 2017, upon which RBS will no longer be obliged to achieve separation and divestment of the business previously described as Williams & Glyn by 31 December 2017.

 

A £750m provision was recognised in RBS's 2016 Annual Results in relation to the previously proposed package of measures. An incremental charge of £50m in relation to the revised package and its implementation costs will be recorded in the RBS H1 2017 results which will be announced 4th August 2017, taking the total provision to £800m.

 

RBS will incur running costs for the duration of the scheme, which are estimated at around £35m and will be substantially incurred before the end of 2019. Furthermore, under the terms of the revised package, should the uptake within the Incentivised Switching Scheme not be sufficient, RBS could be required to make a further contribution, capped at £50m.

 

Ross McEwan, RBS CEO, said "We welcome the progress that HMT and the EC Commissioner responsible for competition have made on agreeing an alternative package of remedies to increase competition in the SME marketplace. We await a formal decision on this proposal which would allow us to resolve our final State Aid divestment obligation."

 

 

Investor Relations

+44 (0) 20 7672 1758

 

RBS Media Relations

+44 (0) 131 523 4205

 

 

 

Forward Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to RBS and its subsidiaries' regulatory capital position, risk-weighted assets, impairment losses and credit exposures under certain specified scenarios. In addition, forward-looking statements may include, without limitation, statements typically containing words such as "intends", "expects", "anticipates", "targets", "plans", "estimates" and words of similar import. These statements concern or may affect future matters, such as RBS's future economic results, business and capital plans and current strategies. Forward-looking statements are subject to a number of risks and uncertainties that might cause actual results and performance to differ materially from any expected future results or performance expressed or implied by the forward-looking statements. Factors that could cause or contribute to differences in current expectations include, but are not limited to, legislative, fiscal and regulatory developments, competitive conditions, technological developments, exchange rate fluctuations and general economic conditions. These and other factors, risks and uncertainties that may impact any forward-looking statement or RBS's actual results are discussed in RBS's UK annual report and accounts and interim reports and materials filed with, or furnished to, the US Securities and Exchange Commission, including, but not limited to, RBS's Reports on Form 6-K and most recent Annual Report on Form 20-F. The forward-looking statements contained in this announcement speak only as of the date of this announcement and RBS does not assume or undertake any obligation or responsibility to update any of the forward-looking statements contained in this announcement, whether as a result of new information, future events or otherwise, except to the extent legally required.

 

MAR

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Matt Waymark, Head of Investor Relations for The Royal Bank of Scotland Group.

 

 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFVEDIIRFID
Date   Source Headline
30th May 20186:21 pmRNSResult of AGM
30th May 20181:55 pmRNSAGM Statement
30th May 201812:55 pmRNSDividend Declaration
30th May 20187:00 amRNSDirectorate Change
18th May 20181:23 pmRNSPublication of Suppl.Prospcts
16th May 201811:17 amRNSPricing of USD Fixed Rate to Floating Rate Notes
15th May 201812:44 pmRNSUpdate on ring-fencing plans
14th May 20182:00 pmRNSDirector/PDMR Shareholding
11th May 20183:18 pmRNSPublication of Suppl.Prospcts
10th May 201810:34 amRNSCapital reduction - notice of petition
10th May 20187:00 amRNSRBS settlement in principle with US DOJ on RMBS
2nd May 201812:38 pmRNSAlternative Remedies Package Deed signed
1st May 20186:12 pmRNSRBS notes credit ratings action by Fitch Ratings
1st May 20185:37 pmRNSPublication of Suppl.Prospcts
1st May 201812:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:08 pmRNSTotal Voting Rights
30th Apr 20182:40 pmRNSDirector/PDMR Shareholding
30th Apr 20187:00 amRNSRing-Fencing Transfer Scheme Effective
27th Apr 20187:02 amRNSRing Fenced Structure - Director Changes
27th Apr 20187:01 amRNSDirectorate Change
27th Apr 20187:00 amRNS1st Quarter Results
26th Apr 20183:04 pmRNSNotice of AGM
25th Apr 20181:00 pmRNSRBS Holdings N.V. & Royal Bank of Scotland N.V.
20th Apr 20184:35 pmRNSDividend Declaration
17th Apr 20186:07 pmRNSAllotment and Issue of New Ordinary Shares
17th Apr 20181:24 pmRNSMoU with Pension Trustee on ring-fencing alignment
13th Apr 201811:32 amRNSBlock listing Interim Review
11th Apr 20186:25 pmRNSPosting of Scheme Document
5th Apr 201812:00 pmRNSUpdate on ring-fencing plans
5th Apr 20187:00 amRNSRBS notes credit ratings action by Moody's
3rd Apr 20187:00 amRNSFILING OF ANNUAL REPORT ON FORM 20-F WITH US SEC
29th Mar 20185:45 pmRNSTotal Voting Rights
29th Mar 20181:19 pmRNSDirector/PDMR Shareholding
27th Mar 201810:15 amRNSRecommended cash offer
27th Mar 20189:59 amRNSRecommended Cash Offer for Freeagent Holdings PLC
26th Mar 20183:18 pmRNSAdditional Listing
23rd Mar 20185:09 pmRNSPublication of Suppl.Prospcts
22nd Mar 20183:21 pmRNSUpdate on ring fencing plans
20th Mar 20188:00 amRNSMorgan Stanley European Financials Conference
16th Mar 20182:37 pmRNSPublication of Final Terms
8th Mar 20184:02 pmRNSDirector/PDMR Shareholding
1st Mar 20186:10 pmRNSDividend Declaration
1st Mar 20183:10 pmRNSDirector/PDMR Shareholding
28th Feb 20186:27 pmRNSPublication of Final Terms
28th Feb 20186:20 pmRNSTotal Voting Rights
28th Feb 20181:37 pmRNSAdditional Listing
23rd Feb 20183:30 pmRNSPublication of Suppl.Prospcts
23rd Feb 20187:02 amRNSDirectorate Change
23rd Feb 20187:01 amRNSAnnual Financial Report
23rd Feb 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.